Blockchain Registration Transaction Record

Cardio Diagnostics to Showcase AI Heart Risk Tools at Benefits Conferences

Cardio Diagnostics Holdings (CDIO) to exhibit AI-powered cardiovascular risk assessments at four national benefits conferences in June 2026, targeting employers and brokers to reduce heart disease costs.

This news matters because cardiovascular disease is the leading cause of death and a major driver of healthcare costs for employers. By using AI-powered tests to identify at-risk individuals earlier, Cardio Diagnostics' offerings could help reduce costly emergency interventions, improve employee health outcomes, and lower overall health plan expenses. For benefits decision-makers, this represents a proactive approach to managing a pervasive health issue that directly impacts productivity and financial stability.